Naab Al‐Saady

951 total citations
15 papers, 713 citations indexed

About

Naab Al‐Saady is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Naab Al‐Saady has authored 15 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 2 papers in Surgery and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Naab Al‐Saady's work include Atrial Fibrillation Management and Outcomes (10 papers), Cardiac Arrhythmias and Treatments (8 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Naab Al‐Saady is often cited by papers focused on Atrial Fibrillation Management and Outcomes (10 papers), Cardiac Arrhythmias and Treatments (8 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Naab Al‐Saady collaborates with scholars based in United Kingdom, United States and Germany. Naab Al‐Saady's co-authors include A. John Camm, Shamil Yusuf, Ed Bennett, Nils Edvardsson, Owen Obel, Mark M. Gallagher, Muriel S. Shannon, Gregory Y.H. Lip, D. Tighe and Michael Melino and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and Critical Care Medicine.

In The Last Decade

Naab Al‐Saady

15 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naab Al‐Saady United Kingdom 10 462 145 119 76 52 15 713
Angel López‐Candales United States 12 341 0.7× 183 1.3× 94 0.8× 104 1.4× 66 1.3× 28 558
Susan C. Fox United Kingdom 16 321 0.7× 64 0.4× 106 0.9× 28 0.4× 57 1.1× 28 650
D Felmeden United Kingdom 13 314 0.7× 102 0.7× 33 0.3× 62 0.8× 100 1.9× 26 567
Francesca A. Nicolini United States 15 441 1.0× 177 1.2× 61 0.5× 70 0.9× 116 2.2× 30 806
Nikolaos Kakouros United States 14 729 1.6× 212 1.5× 50 0.4× 172 2.3× 53 1.0× 71 998
M. Pastorelli Italy 16 230 0.5× 270 1.9× 30 0.3× 55 0.7× 60 1.2× 30 600
Willy Weng Canada 8 354 0.8× 237 1.6× 109 0.9× 27 0.4× 35 0.7× 17 544
Hsin‐Fu Lee Taiwan 19 859 1.9× 158 1.1× 311 2.6× 122 1.6× 50 1.0× 58 1.1k
Michael Stuart Garfinkle Canada 4 625 1.4× 61 0.4× 51 0.4× 37 0.5× 35 0.7× 5 721
M. Teresa Santos Spain 8 214 0.5× 107 0.7× 116 1.0× 21 0.3× 50 1.0× 13 535

Countries citing papers authored by Naab Al‐Saady

Since Specialization
Citations

This map shows the geographic impact of Naab Al‐Saady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naab Al‐Saady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naab Al‐Saady more than expected).

Fields of papers citing papers by Naab Al‐Saady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naab Al‐Saady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naab Al‐Saady. The network helps show where Naab Al‐Saady may publish in the future.

Co-authorship network of co-authors of Naab Al‐Saady

This figure shows the co-authorship network connecting the top 25 collaborators of Naab Al‐Saady. A scholar is included among the top collaborators of Naab Al‐Saady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naab Al‐Saady. Naab Al‐Saady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Yi, B. Alexander, Debra Freedholm, Xiaohui Wang, et al.. (2021). Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa. Journal of Thrombosis and Haemostasis. 20(2). 307–315. 72 indexed citations
2.
Goette, Andreas, Luciana Summo, Alexander Gebauer, et al.. (2020). Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II study. IJC Heart & Vasculature. 29. 100573–100573. 7 indexed citations
3.
Kozieł, Monika, Naab Al‐Saady, Søren Pihlkjær Hjortshøj, et al.. (2020). Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial. Clinical Research in Cardiology. 109(8). 1018–1024. 3 indexed citations
4.
Lip, Gregory Y.H., José Luís Merino, Maciej Banach, et al.. (2020). Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomized trial. Journal of Arrhythmia. 36(3). 430–438. 8 indexed citations
5.
Lip, Gregory Y.H., Naab Al‐Saady, Michael D. Ezekowitz, Maciej Banach, & Andreas Goette. (2017). The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. American Heart Journal. 193. 16–22. 7 indexed citations
6.
7.
Goette, Andreas, José Luís Merino, Michael D. Ezekowitz, et al.. (2016). Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial. The Lancet. 388(10055). 1995–2003. 177 indexed citations
8.
Kastelein, John J.P., Joost Besseling, Sukrut Shah, et al.. (2015). Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study. The Lancet. 385(9983). 2153–2161. 80 indexed citations
9.
Arno, Gavin, Nicholas D. Carter, Petros Syrris, et al.. (2004). Quantification of mitochondrial sublimons in human fibrillating atria. Clinical Science. 106(6). 653–659. 2 indexed citations
10.
Yusuf, Shamil, Naab Al‐Saady, & A. John Camm. (2003). 5‐Hydroxytryptamine and Atrial Fibrillation:. Journal of Cardiovascular Electrophysiology. 14(2). 209–214. 36 indexed citations
11.
Yusuf, Shamil, Naab Al‐Saady, & A. John Camm. (2003). 5-hydroxytryptamine and atrial fibrillation: how significant is this piece in the puzzle?. PubMed. 14(2). 209–14. 47 indexed citations
12.
Gallagher, Mark M., Nils Edvardsson, Muriel S. Shannon, et al.. (2002). Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion. Journal of the American College of Cardiology. 40(5). 926–933. 127 indexed citations
13.
Tighe, D., et al.. (1995). Goal-directed therapy with dopexamine, dobutamine, and volume expansion. Critical Care Medicine. 23(12). 1997–2007. 40 indexed citations
14.
Webb, Andrew, et al.. (1991). Advantages of a narrow-range, medium molecular weight hydroxyethyl starch for volume maintenance in a porcine model of fecal peritonitis. Critical Care Medicine. 19(3). 409–416. 45 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angel López‐Candales Breakdown of academic impact, for papers by Susan C. Fox Breakdown of academic impact, for papers by D Felmeden Breakdown of academic impact, for papers by Francesca A. Nicolini Breakdown of academic impact, for papers by Nikolaos Kakouros Breakdown of academic impact, for papers by M. Pastorelli Breakdown of academic impact, for papers by Willy Weng Breakdown of academic impact, for papers by Hsin‐Fu Lee Breakdown of academic impact, for papers by Michael Stuart Garfinkle Breakdown of academic impact, for papers by M. Teresa Santos
Rankless by CCL
2026